This page describes the legal instructions which apply to every Internet-user visiting this site. In consulting this site you undertake to respect these instructions without reservation. We advise you to consult these instructions regularly, as they may be modified from time to time and without notice
1. Intellectual property
The www.sanofi.com website (hereinafter the “site”) is owned and operated by Sanofi-aventis Groupe, belonging to Groupe Sanofi. The presentation and each of the elements, including trademarks, logos and domain names appearing on the site are protected by intellectual property laws and (i) are held by Sanofi-aventis Groupe or its subsidiaries or (ii) are held by third parties and are subject to an authorization of use granted to Sanofi-aventis Groupe by their owners, including those listed in Article 10 below.
No material from the site may be copied, reproduced, modified, republished, uploaded, distorted, transmitted or distributed in any manner or in any medium, in part or in whole, without the prior written consent of Sanofi-aventis Groupe, except strictly for the purposes of the press and subject to the respect of intellectual property rights and any other proprietary right that is mentioned. Only copying for private usage is permitted for your personal, private and non-commercial use, on your personal computer or through sharing tools offered on the site.
The following notice shall appear on all copies authorized in whole in or in part of the site’s content: “COPYRIGHT SANOFI 2004-2022. ALL RIGHTS RESERVED.”
Elements composing or contained in the site authorized for use may not be distorted, modified or altered in any way.
Sanofi or its subsidiaries reserve the right to take legal action against any counterfeit of its intellectual property rights.
2. Nature of information
The information, notably financial information, provided on the site shall not be considered as an invitation to invest. They shall not be interpreted as canvassing or public offering, and do not constitute either an offer to subscribe, purchase, or deal in Sanofi shares or any other securities issued by Sanofi and/or its subsidiaries. Sanofi-aventis Groupe draws your attention to the fact that financial information posted on the site are regularly updated.
As the case may be, expert opinions concerning a particular area in relation with the content of the site shall be posted on the site, or extracts from press articles. Such information represents only the opinions of the respective experts or of the newspaper, which opinions are not necessarily those of the Sanofi Group. Such experts are not employees of the Sanofi Group and do not receive any compensation from Sanofi-aventis Groupe for the use of their opinion. Sanofi-aventis Groupe is not responsible for the accuracy or completeness of any information or opinions set forth in such materials. Expert advice reflects only the personal view of that expert, and in no case shall it be regarded as the opinion or responsibility of Sanofi-aventis Groupe.
Moreover, the site contains information relating to health, fitness, the medical domain and various kinds of medical treatment reserved exclusively for use by human beings. This is for information purposes only and is not meant to be a substitute for the advice provided by your own physician or pharmacist. You should not use the information contained herein for diagnosing any illness or physical problem or in order to prescribe or use any medication presented on the site. You should always consult your own physician or pharmacist.
3. Links to other sites
The responsibility of Sanofi-aventis Groupe will not be called into account with regard to any third-party site to which you may have gained access via the site. We have no way of controlling the content of these third-party sites which remain totally independent of Sanofi-aventis Groupe. In addition, the existence of a link between the site and any third party site in no way implies that Sanofi-aventis Groupe in any way approves of the content of this site, or, moreover, any use to which such content may be put.
Furthermore, it is your responsibility to take the necessary precautions to prevent the site being contaminated by, including, but not limited to, one or more “viruses”, “Trajan horses” or any other “parasites”.
External sites may contain hyperlinks leading to the site. Any such hyperlink shall not be installed without Sanofi-aventis Groupe’s express prior consent. In any case, Sanofi-aventis Groupe is in no way responsible for the unavailability of such external sites and Sanofi-aventis Groupe does not review, control, approve, nor is it responsible for any content, advertising, products or other materials available on or accessible via those sites.
4. Privacy, Protection of Personal Data and Confidential Information
4.1 Privacy and protection of Personal Data
Sanofi-aventis Groupe is data controller for the processing of personal data collected through this website.
54, rue La Boétie
Tel.: +33 (0)1 53 77 40 00
Sanofi-aventis Groupe is a public company with capital of 76,493,456 euros, registered with the RCS of Paris under the number 403 335 938 (SIREN).
4.2 The site is not designed to receive any confidential information which you may submit.
Consequently, and except for the personal data mentioned above, any information in whatever form - documents, data, graphics, questions, suggestions, concepts, remarks or other - which you communicate on the website will in no way be deemed confidential. Consequently, the mere transmission by you gives us the right to use, reproduce, distribute, modify or transmit this information in order to process your request.
5. Limitations of liability
Sanofi-aventis Groupe makes every effort to ensure to the best of its abilities the accuracy and updating of the information broadcast on the site, whose content the company reserves the right to change at any time and without prior notice. Nonetheless, Sanofi-aventis Groupe cannot fully guarantee the accuracy, precision, updating or exhaustiveness of the information made available on the site.
As a result, and with the exception of direct damage resulting from willful misconduct or gross negligence by Sanofi-aventis Groupe, the latter cannot be held liable for:
- any imprecision, inaccuracy or omission relative to the information provided on the site;
- any damage resulting from fraudulent intrusion by a third party leading to the modification of the information or materials provided on the site;
- in a more general way, any damage, direct or indirect, regardless of its cause, origin, nature or consequences, even whilst Sanofi-aventis Groupe has been aware of the possibility of such damage, whether it be the result of (i) access or inability to access the site, (ii) the use of the site, including any damage or virus which may infect your computer system or any other product, and/or (iii) credit given to any information provided directly or indirectly by the site
The materials in the site and all other sites are provided “as is”, without any kind of warranty, whether express or implied. Sanofi-aventis Groupe does not offer any express or implied warranty relative without limitation to their merchantability and fitness for a particular purpose.
6. Availability of the web site
You acknowledge that (i) it is technically impossible that the site will be provided free of defaults and that Sanofi-aventis Groupe cannot take any responsibility for this, (ii) that defaults may lead to the temporary unavailability of the site, and that (iii) the operation of the site may be adversely affected by conditions and performances outside Sanofi-aventis Groupe’s control, such as, for example, transmission and telecommunication links between Sanofi-aventis Groupe and you and between Sanofi-aventis Groupe and other systems and networks.
Sanofi-aventis Groupe and/or its suppliers may, at any time, temporarily or in permanently modify or interrupt, all or part of the site in order to perform maintenance work and/or make improvements and/or changes to the site. Sanofi-aventis Groupe is not liable for any modification to or suspension or interruption of the site.
7. Information on the products
The information contained and broadcast on the site may contain direct or indirect references to products, programs and services of the Sanofi Group which are not proposed or available in certain countries or regions, or which may be offered under a different trademark, and which may be subject to different regulations and conditions of use according to the country. Such references do not imply any intention on the part of the Sanofi Group to sell these products, programs or services in your country. Please consult the local Sanofi Group subsidiary or your Sanofi Group commercial partner for any information concerning the products, programs and services which are available in your region / country.
8. Legal framework
The site and its content are governed by the Laws of France. Any possible litigation referring to the site and its content will come under the competence of French Courts.
9. Legal notice
9.1 Site Editor
54, rue La Boétie
FR - 75008 Paris
Tel.: +33 (0)1 53 77 40 00
Sanofi-aventis Groupe, a corporation (société anonyme) with a capital of 76,493,456 Euros, registered in the Paris Trade and Company Register under Number 403 335 938.
9.2 Publishing Director
Chairman and Chief Executive Officer of Sanofi-aventis Groupe
CEO Sanofi Pasteur
9.3 Site hosting
Microsoft Nederland B.V.
Evert van de Beekstraat 354
1118 CZ Schiphol (Amsterdam)
Microsoft Nederland B.V. is part of Microsoft Corporation,
1 Microsoft Way,
98052 Redmond, Washington, USA.
This section describes Sanofi-aventis Groupe social media community guidelines which apply to users interacting with Sanofi-aventis Groupe global social media channels. In using these channels, users undertake to respect these instructions without reservation. Sanofi advises users to consult these instructions regularly, as they may be modified from time to time and without prior notice.
These instructions complement the Terms and conditions for Twitter, LinkedIn, YouTube, Facebook and Instagram. By interacting with the Sanofi-aventis Groupe global social media channels accounts (as defined hereto), users agree to abide by these terms as well as theTwitter, LinkedIn, YouTube, Facebook and Instagram Terms and conditions.
Information about which entity runs the social media accounts is seen at the very beginning of the French version of Sanofi’s website. So we can put the paragraph about it here just after the introduction of the Social Term of use.
Sanofi-aventis Groupe global social media channels : Twitter (Sanofi, General Medicine at Sanofi, Vaccines at Sanofi, & Specialty Care at Sanofi), LinkedIn (Sanofi, Vaccines at Sanofi & Specialty Care at Sanofi), Instagram (Sanofi, Specialty Care at Sanofi), YouTube (Sanofi, Vaccines at Sanofi & Specialty Care at Sanofi) and Facebook (Sanofi, Vaccines at Sanofi & Specialty Care at Sanofi).
Interaction: Any interaction with the Sanofi-aventis Groupe global social media channels, such as commenting on a post, sending a direct message , following Sanofi-aventis Groupe global social media channels, liking a post, sharing a post, forwarding or copying a picture/video or any other visual asset through user’s personal or company social media accounts.
Sanofi Content: text or multimedia content, published by a Sanofi-aventis Groupe global social media channel.
Third-party Content: content published by social media accounts other than those of Sanofi-aventis Groupe.
10.2 Purpose of Sanofi-aventis Groupe global social media channels
Sanofi-aventis Groupe global social media channels are targeted towards a global audience and intended to share public, institutional information (hereafter referred to as “Sanofi Content”) about Sanofi, company’s activities, or associated projects and initiatives.
As Sanofi-aventis Groupe operates in a highly regulated industry, the type of information and content which can be shared and discussed through these channels is limited. Sanofi Content published via these channels may contain information or details regarding some of Sanofi-aventis Groupe activities that are not available or accessible in every country. For question(s) about Sanofi activities or its products in a specific country, users should contact their local Sanofi office.
10.3 Interacting with Sanofi-aventis Groupe global social media channels
By interacting with Sanofi-aventis Groupe global social media channels, users grant Sanofi-aventis Groupe a worldwide, non-exclusive, royalty-free license (with the right to sublicense) to use, copy, reproduce, process, adapt, modify, publish, transmit, display and distribute such Third-party content in any and all media or distribution methods now known or later developed, for the duration of the protection of intellectual property. In that respect, the user guarantees Sanofi-aventis Groupe that he/she has, or has obtained, all consents, licenses, rights, or permissions necessary to grant such rights to Sanofi-aventis Groupe and that such content do not infringe any intellectual property rights or any proprietary rights of any third party.
If a user publishes a post tagging Sanofi-aventis Groupe global social media channels through their personal or professional social media channels, Sanofi has the right to un-tag itself, or to relay the content over social media without giving prior notice to the user. Relaying Third-party Content on Sanofi-aventis Groupe global social media channels could be in the form of functionalities native to the platform (for example, “like”, “comment”, “share”) and these functionalities might change over time without prior notice.
The Sanofi Content may not be copied, reproduced, modified, republished, uploaded, distorted, transmitted or distributed in any manner or in any medium, in part or in whole, without the prior written consent of Sanofi-aventis Groupe, except strictly for the purposes of using the Sanofi-aventis Groupe global social media channels, and subject to the respect of intellectual property rights and any other proprietary right that is mentioned.
Users can copy Sanofi Content for their own private and non-commercial usage, on their personal computer, mobile device, or through sharing tools offered on the site and social media channels.
Any right not expressly granted to the user by these terms remains the right of Sanofi-aventis Groupe or the respective rights holders.
We draw users’ attention to the fact that all Internet users can access the information they publish on Sanofi-aventis Groupe global social media channels such information is therefore considered to be public information.
Language of Interaction
Sanofi-aventis Groupe global social media channels are intended for a worldwide audience. The primary language is English, but other languages may be used. In the event users communicate with the Sanofi-aventis Groupe social media channels in another language than English, Sanofi-aventis Groupe cannot guarantee that users will receive a response.
Guidelines on interacting with Sanofi-aventis Groupe global social media channels
Sanofi-aventis Groupe welcomes feedback and ideas from all users of Sanofi-aventis Groupe global social media channels and endeavors to respond whenever and wherever possible. However, Sanofi-aventis Groupe is not able to reply individually to all comments and messages received over its global social media channels.
Interaction on Sanofi-aventis Groupe global social media channels are governed by the following guidelines. Without prior notice, Sanofi-aventis Groupe reserves the right to block and report a user’s activity to authorities, delete posts, graphics, comments, videos, photos, or any other content that falls under the following categories but is not limited to:
- Promoting or calling for violence towards any segment of the society
- Potential defamation or libel
- Violating copy rights or intellectual property rights
- Promoting illegal activity
- Sharing any misleading or fraudulent information
- Using language that is not appropriate (abusive, discriminatory or harassing)
- Sharing medical advice, treatments or offering medicines or medical devices to other followers
- Advertising a company/business or any product/brand
- Sharing content unrelated to the post under which it appears
- Repetitively posting or “spamming’’
- Using Sanofi-aventis Groupe global social media channels in breach of any condition set forth in these terms or applicable laws.
Sanofi-aventis Groupe is not responsible for Interactions of users with the channels, and does not approve or endorse third parties’ Interactions with the channels. Sanofi-aventis Groupe may, at any time, temporarily or permanently, modify, or delete, all or part of the content published on Sanofi-aventis Groupe global social media channels to make improvements and/or changes to the account. To the full extent possible by law, Sanofi-aventis Groupe will not be responsible nor liable for any damages directly resulting from user’s use, or inability to use, the content published on Sanofi-aventis Groupe global social media channels.
Messages, texts, images as well as any other contribution made on Sanofi-aventis Groupe global social media channels shall not be considered as an invitation to invest. They shall not be interpreted as canvassing or public offering and do not constitute either an offer to subscribe, purchase or deal in Sanofi shares or any other securities issued by Sanofi and/or its Affiliates.
Third parties’ activities
Sanofi-aventis Groupe does not approve or endorse any third parties’ Interactions with Sanofi-aventis Groupe global social media accounts or more generally any information and content posted by third parties on these channels even when they relate to its products or activities, nor does it guarantee their accuracy. Caution should be used before relying on any particular statements or opinions expressed by a third party. The Sanofi-aventis Groupe global social media accounts may follow other social media accounts and like, comment or share content posted by these third parties. Such Interactions shall not be considered as an endorsement of those media accounts or of their activities, unless otherwise expressly confirmed in writing. Sanofi-aventis Groupe shall not be held responsible for the activity of the social media accounts it follows, or from which it selects to engage with through its social media channels. Moreover, the posting of an external web link by the Sanofi-aventis Groupe global social media channels directing towards a third-party’s social media channel, website or content shall not be considered as an endorsement and Sanofi-aventis Groupe should not be held liable if the content of these websites changes over time.
Personal Data and Information
Your personal data will be processed under the responsibility of Sanofi Aventis Groupe in order to :
- Monitor and improve Sanofi online activity and performance on social media
- Monitor accordingly pharmacovigilance cases on social media.
In order to achieve this purpose, your profile picture, username, and status that mention Sanofi or Sanofi’s products, will be processed, on the basis of Sanofi legitimate interests.
Your data will be processed in a confidential and secure way and their authorized recipients only are :
- Sanofi contractors
- Sanofi employee in charge of pharmacovigilance, compliance, communications or any other department.
Your data may be transferred outside of the European Economic Area. In such a case, Sanofi implements adequate safeguards such as the Standard Contractual Clauses.
Your data will be kept only for the necessary time to achieve the above mentioned purpose, and in any case, no longer than 2 years.
According to applicable data protection law, you may have the rights to:
- Access your personal data
- Ask for the rectification or erasure of your personal data
- Restrict their processing or object to
In order to exercise these rights, please click here.
If you deem that your rights have not been respected, you have the right to lodge a complaint to the data protection authority in your country.
Governing law and disputes
These terms shall be governed, construed and enforced in accordance with the laws of France, without regard to principles of conflict of laws. Any claim or dispute arising between a user and Sanofi-aventis Groupe in connection with these terms shall be resolved through an amicable solution (users can contact us at https://www.sanofi.com/en/contact). In case no amicable solution is reached between the parties, the dispute shall be decided exclusively by a court of competent jurisdiction located in France.
11.1 Register trademarks
- Apple®, the Apple® logo, iPhone®, iPod touch® and App Store® are trademarks of Apple Inc. registered in the United States of America and other countries.
- Trademarks and logos Google®, YouTube® and g+® are trademarks of Google Inc. registered in various countries.
- Flickr® trademarks and logos are registered trademarks on behalf of Yahoo! Inc. in various countries.
- LinkedIn® trademarks and logos are registered trademarks in the United States of America and/or in other countries in the name of LinkedIn Corporation or its affiliated companies.
- All SlideShare® trademarks and logos are registered to SlideShare, Inc. in the United States of America and/or other countries.
- Twitter® trademarks and logos are Twitter Inc. brands, registered in various countries.
The use of some of these brands on the website does not imply that their respective owners approve the contents of the website. These third parties are and remain totally independent of Sanofi-aventis Groupe.
11.2 Photo credits
Colin Hawlins/Getty Images; Peter Samuels/Getty Images; Han Lans/Getty Images; commerceandculturestock/ Getty Images; GettyImages/Caiaimage Paul Bradbury; Sanofi Pasteur/Gautam Dhimal; Hadynyah/Getty Images; Jupiterimages; Ronnie Kaufman/Larry Hirshowitz; Blend Images/KidStock; fstop123; sturti/Getty Images; Aaron Black/Getty Images; Imgorthand; Cultura RM Exclusive/Edwin Jimenez/Getty Images; Wundervisuals/Getty Images; Pekic/Getty Images; Portra/Getty Images; Geber86/Getty Images; PeopleImages.com/Ocean/Getty Images; JAG Images/Getty Images; PeopleImages/Getty Images; Pixelfit/iStock; Petar Chernaev/Getty Images; David Walters/iStock; Erickson/Jim Erickson/plainpicture; Geber86/iStock; freemixer/Getty Images; PIERRE-OLIVIER/Capa Pictures/SANOFI; Martin Puddy/Getty Images; Poba/iStock; Patrice Maurein; Sanofi; Franck Parisot; Alex Cretey Systermans; Peter Allan; Gil Lefauconnier; Céline Clanet; Peter Allan/Interlinks Image; iStock/D-Keine; iStock/filipefrazao; Istock/Halfpoint; Marizilda Cruppe; iStock/Steve Debenport
Science & innovation
Commerceandculturestock/Getty Images; Matej Kastelic/iStock; Maruzhenko Yaroslav/iStock; Denis ALLARD/REA; poba/Getty Images; CAPA Pictures; monkeybusinessimages/Getty Images; Patrick ALLARD/REA; Morsa Pictures; Sanofi Pasteur/Axelle Bernard; gpointstudio/iStock; Petar Chernaev/iStock; PeopleImages/iStock; Ridofranz/iStock; Sturti/iStock; Steve Debenport/iStock; franckreporter/Getty Images; Peter Allan; Rémi Duhamel/Image In; Getty Images; Vladimir Vladimirov/iStock; Pierre Olivier/CAPA pictures; Cecilie_Arcurs/iStock; iStock/NicoElNino
GettyImages / Caiaimage Paul Bradbury; Martin Puddy/Getty Images; Robru/iStock; HO/AFP Photo; iStock/FatCamera; Tang Ming Tung/Getty Images; Sanofi US; Joakimbkk/iStock; Franck Parisot; Nga Nguyen/Getty Images; commerceandculturestock/Getty Images; Rawpixel/Getty Images; iStock; Rémi Duhammel/Image In Production; PeopleImages.com/Ocean/Getty Images; FatCamera/Getty Images; Andrew Marinkovich/Getty Images; Paul Bradbury; iStock/Jedraszak; iStock/Simonkolton; iStock/Vikialis
Geber86/Getty images; poba/Getty Images; PIERRE-OLIVIER/Capa Pictures/SANOFI; Pekic/Getty Images; commerceandculturestock/ GettyImages; Petar Chernaev/Getty Images; PeopleImages/iStock; Sam Edwards/iStock; MStudioImages /iStock; Petar Chernaev; PeopleImages/GettyImages; Geoges Blonsky/CAPA Pictures
Morsa pictures; Denis ALLARD/REA; OJO Images/Getty Images; andresr/iStock; Patrice Maurein; Franck Parisot; kasto80/iStock; Christian Fleury; PIERRE-OLIVIER/Capa Pictures/SANOFI; Randy Monceaux/Sanofi Pasteur; Patrick ALLARD/REA; CAPA Pictures; CELINE CLANET/Interlinks; poba/Getty Images; Geber86/Getty Images; Petar Chernaev; Steve Cole/iStock; Electra K.Vasileiadou u/iStock; Steve Cole/iStock
AleksandarNakic/iStockphoto; PeopleImages/iStockphoto; Alexis Chezière/Sanofi Pasteur; Christoph Burgstedt/Gettyimages; Pierre Olivier/Capa Pictures
Value of vaccines
hoozone/iStockphoto; pixelfit/iStockphoto; Geber86/iStockphoto; Choreograph/iStockphoto ; PeopleImages/iStockphoto; Kikovic/Sanofi/iStockphoto
Vaccination saves lives
Choreograph/iStockphoto ; Norbert Domy/Sanofi Pasteur; Norbert Domy/Sanofi Pasteur; Gautham Dhimal/Sanofi Pasteur
Alexis Chezière/Sanofi Pasteur; Sanofi Pasteur; Patrick Boulen/Sanofi Pasteur; Alexis Chezière/Sanofi Pasteur; Alexis Chezière/Sanofi Pasteur; Randy Monceaux/Sanofi Pasteur; Patrick Boulen/Sanofi Pasteur
Vaccines for Tomorrow
Christoph Burgstedt/Gettyimages; Alexis Chezière/Sanofi Pasteur
Hadynyah/Gettyimages; Benjamin Dahl, Ph.D., M.P.H.; Benjamin Dahl, Ph.D., M.P.H.
FilippoBacci/Gettyimages; Sanofi Pasteur; Sanofi Pasteur/Marizilda Cruppe; Sanofi Pasteur/Marizilda Cruppe
Haemophilus influenzae type b infections (Hib)
Vesnaandjic/iStockphoto; SDI Productions/iStockphoto; Vincent Moncorgé/Sanofi Pasteur
Jose Luis Pelaez Inc/GettyImages; Vincent Moncorge/Sanofi Pasteur; Randy Monceaux/Sanofi Pasteur; DGLimages/iStockphoto; Sanofi Pasteur
Liderina/Shutterstock; fizkes/Shutterstock; fizkes/Shutterstock; NadyaEugene/Shutterstock
Meningococcal meningitis for parents
FatCamera/iStockphoto; Geber86/iStockphoto; Catherine Delahaye/GettyImages
Bambasi Prod; Bambasi Prod; David Sacks/Getty Images
Respiratory Syncytial Virus
Vesnaandjic/GettyImages; Youngoldman/GettyImages; monkeybusinessimages/GettyImages; RuslanDashinsky/iStockphoto; PeopleImages/iStockphoto; Jasonfang/GettyImages
pixelfusion3d/GettyImages; Norbert Domy/Sanofi Pasteur
Tempura/iStockphoto; SolStock/iStockphoto; Van Truan/Fotolia/AdobeStock
Bartosz Hadyniak/iStockphoto; martin-dm/iStockphoto
Updated on January 4, 2022